Tyrosine for Methamphetamine Dependence - 1

Completed · Phase 2

Conditions studied: Amphetamine-Related Disorders

In brief

The purpose of this study is to evaluate efficacy of tyrosine as a treatment for methamphetamine dependence in an outpatient treatment setting providing group psychosocial interventions. Examine effect of tyrosine on abstinence, retention in treatment, and craving."

Key facts

Study ID

NCT00000322

Run by

National Institute on Drug Abuse (NIDA)

People needed

89

Starts

1997-04-01

Expected to finish

2001-12-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18-65 years of age. Able to provide informed consent. Desire to reduce/eliminate methamphetamine use. Used within the past two weeks. Meet DSM criteria for methamphetamine dependence.

You may not qualify if…

• No dependence (within the past 12 months) for other durgs except nicotine. No history or family history of tyrosine intolerance.

Where it is running

• Haight Ashbury Free Clinics — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.